Poly-ε-caprolactone (PCL), a promising polymer for pharmaceutical and biomedical applications: Focus on nanomedicine in cancer

Poly-ε-caprolactone (PCL) has been the subject of extensive research in the past few years. It is widely explored in drug delivery, where the development of nanomedicines for cancer, one of the major public health concerns nowadays, has not been the exception. As a biocompatible, biodegradable and b...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of polymeric materials Vol. 69; no. 2; pp. 85 - 126
Main Authors Espinoza, Sergio Miguel, Patil, Harshal Indrabhan, San Martin Martinez, Eduardo, Casañas Pimentel, Rocio, Ige, Pradum Pundlikrao
Format Journal Article
LanguageEnglish
Published Taylor & Francis 22.01.2020
Subjects
cancer
drug delivery systems
Nanomedicine
poly-ε-caprolactone
polymeric nanostructures
Online AccessGet full text
ISSN0091-4037
1563-535X
DOI10.1080/00914037.2018.1539990

Cover

More Information
Summary:Poly-ε-caprolactone (PCL) has been the subject of extensive research in the past few years. It is widely explored in drug delivery, where the development of nanomedicines for cancer, one of the major public health concerns nowadays, has not been the exception. As a biocompatible, biodegradable and bioresorbable polymer, PCL has also found plenty of uses in the form of microparticles and scaffolds; so is the main objective of the present review to emphasize its potential and present its properties along with applications in the pharmaceutical and biomedical area with a special focus on nanomedicine in cancer.
ISSN:0091-4037
1563-535X
DOI:10.1080/00914037.2018.1539990